Details for 2018755604
Up to date per 04.04.2026
Actions
Details for 2018755604
Granted/Registered
European Patent
03.06.2020 A
06.09.2023 B1
27.07.2017
US
201762537741 P
A61K 39/395 20060101AFI20190201BHEP
Owner
Alexion Pharmaceuticals, Inc.121 Seaport Boulevard Boston, MA 02210US
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT
Inventor
ORTIZ, Stephan31 Dover Court Guilford CT 06437US
GENTILE, Jillian29 Wolf Hill Road Southington CT 06489US
PHILOMINATHAN, Leena130 Copper Beech Drive Cheshire CT 06410US
ROUTHIER, Ericc/o Alexion Pharmaceuticals, Inc. 121 Seaport Boulevard Boston MA 02210US
MASON, Bruce31 Lenore Drive Madison CT 06443US
Information about Fees